Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.
News|Videos|July 1, 2024
Learn about the MyFreeStyle program
Advertisement
Advertisement
Related to this article
Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.
An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
Type 1 and type 2 diabetes reports emphasize areas where pharmacists can act now, including CGM, cardio-kidney therapies, and equitable patient access.
Advertisement
Advertisement
Trending on Drug Topics
1
The Outcome-Based Program That Could Reshape Pharmacists’ Roles
2
Pharmacist-Led Transitions of Care Could Be Crucial in HIV Treatment
3
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
4
Wicked Good Cardiometabolic Chat: Ketone Monitoring in Pharmacy Practice
5